Athenex Gets FDA Compounding Policy Wrong, Amicus Says
Compounder Athenex Pharma Solutions LLC is wrongly attempting to broaden a U.S. Food and Drug Administration policy governing bulk compounding, and its "gross misinterpretation" must be kept out of Par Pharmaceutical's...To view the full article, register now.
Already a subscriber? Click here to view full article